Adler Eric Insider Trades

Insider Trading History

Track insider trading activity for Adler Eric. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Lexeo Therapeutics
Lexeo Therapeutics LXEO
Chief Medical Officer
Holding Value $347k 72,646 shares
Last Trade
Nov 18, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.7k 615 shares
$9.27
$4.78
Lexeo Therapeutics
Lexeo Therapeutics LXEO
Chief Medical Officer
Holding Value $350k 73,299 shares
Last Trade
Oct 17, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$30.3k 3,382 shares
$8.95
$4.78
Lexeo Therapeutics
Lexeo Therapeutics LXEO
Chief Medical Officer
Holding Value $366k 76,643 shares
Last Trade
Oct 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$84.5k 9,570 shares
$8.83
$4.78
Lexeo Therapeutics
Lexeo Therapeutics LXEO
Chief Medical Officer
Holding Value $321k 67,073 shares
Last Trade
Aug 18, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.84k 608 shares
$4.67
$4.78
Lexeo Therapeutics
Lexeo Therapeutics LXEO
Chief Medical Officer
Holding Value $324k 67,681 shares
Last Trade
May 16, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.9k 585 shares
$3.24
$4.78
Lexeo Therapeutics
Lexeo Therapeutics LXEO
Chief Medical Officer
Holding Value $326k 68,266 shares
Last Trade
Feb 19, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$10.4k 2,359 shares
$4.41
$4.78
Lexeo Therapeutics
Lexeo Therapeutics LXEO
Chief Medical Officer
Holding Value $418k 87,500 shares
Last Trade
Jan 07, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$641k 87,500 shares
$7.33
$4.78

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up